Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Unveiling Key Insights for Coca-Cola Europacific Investors

It's been a great morning session for Coca-Cola Europacific investors, who saw their shares rise 1.3% to a price of $91.79 per share. At these higher prices, is the company still fairly valued? If you are thinking about investing, make sure to check the company's fundamentals before making a decision.

an Increase in Expected Earnings Improves Value but Trading Above Its Fair Price:

Coca-Cola Europacific Partners PLC, together with its subsidiaries, produces, distributes, and sells a range of non-alcoholic ready to drink beverages. The company belongs to the Consumer Staples sector, which has an average price to earnings (P/E) ratio of 25.91 and an average price to book (P/B) ratio of 3.03. In contrast, Coca-Cola Europacific has a trailing 12 month P/E ratio of 26.5 and a P/B ratio of 4.98.

Coca-Cola Europacific has moved 24.5% over the last year compared to 11.9% for the S&P 500 — a difference of 12.6%. Coca-Cola Europacific has a 52 week high of $92.73 and a 52 week low of $71.49.

Generally Positive Cash Flows but Not Enough Current Assets to Cover Current Liabilities:

2019 2020 2021 2022 2023 2024
Revenue (M) $12,017 $10,606 $13,763 $17,320 $18,302 $20,438
Gross Margins 38% 35% 37% 36% 37% 35%
Net Margins 9% 5% 7% 9% 9% 7%
Net Income (M) $1,090 $498 $988 $1,521 $1,669 $1,444
Net Interest Expense (M) -$96 -$111 -$129 -$114 -$120 -$187
Diluted Shares (M) 456 455 456 457 459 461
Earnings Per Share $2.32 $1.09 $2.15 $3.29 $3.63 $3.08
EPS Growth n/a -53.02% 97.25% 53.02% 10.33% -15.15%
Free Cash Flow (M) $1,904 $1,490 $2,117 $2,932 $2,806 $3,061
Total Debt (M) $5,622 $6,382 $11,790 $10,571 $10,096 $9,940
Current Ratio 0.75 0.98 0.95 0.89 0.91 0.81
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS